Stereotactic ablative radiotherapy for the management of spinal metastases: a review
Importance Rising cancer incidence combined with improvements in systemic and local
therapies extending life expectancy are translating into more patients with spinal metastases. …
therapies extending life expectancy are translating into more patients with spinal metastases. …
[HTML][HTML] Induction chemotherapy prior to surgery with or without postoperative radiotherapy for oral cavity cancer patients: systematic review and meta-analysis
Background Locoregionally advanced oral cavity cancers are aggressive tumours with high
risk of relapse after definitive treatment. This study was performed to assess the …
risk of relapse after definitive treatment. This study was performed to assess the …
The use of bolus in postmastectomy radiation therapy for breast cancer: A systematic review
Purpose Post mastectomy radiation therapy (PMRT) reduces locoregional recurrence (LRR)
and breast cancer mortality for selected patients. Bolus overcomes the skin-sparing effect of …
and breast cancer mortality for selected patients. Bolus overcomes the skin-sparing effect of …
A Delphi study and International Consensus Recommendations: The use of bolus in the setting of postmastectomy radiation therapy for early breast cancer
Bolus serves as a tissue equivalent material that shifts the 95–100% isodose line towards the
skin and subcutaneous tissue. The need for bolus for all breast cancer patients planned for …
skin and subcutaneous tissue. The need for bolus for all breast cancer patients planned for …
Appropriateness of the 30-day expected mortality metric in palliative radiation treatment: a narrative review
…, J Kazmierska, M Spałek, GN Marta… - Annals of palliative …, 2023 - zora.uzh.ch
BACKGROUND AND OBJECTIVE The 30-day expected mortality rate is frequently used as
a metric to determine which patients benefit from palliative radiation treatment (RT). We …
a metric to determine which patients benefit from palliative radiation treatment (RT). We …
Advances in radiotherapy in bone metastases in the context of new target therapies and ablative alternatives: A critical review
AG Gouveia, DCW Chan, PJ Hoskin, GN Marta… - Radiotherapy and …, 2021 - Elsevier
In patients with bone metastases (BM), radiotherapy (RT) is used to alleviate symptoms,
reduce the risk of fracture, and improve quality of life (QoL). However, with the emergence of …
reduce the risk of fracture, and improve quality of life (QoL). However, with the emergence of …
A critical evaluation of quality of life in clinical trials of breast cancer patients treated with radiation therapy
GN Marta, FY Moraes, ETT Leite… - Annals of palliative …, 2018 - apm.amegroups.org
The aim of this study was to investigate the extent to which health-related quality of life (HRQOL)
parameters have been reported in phase III trials with breast cancer patients (BCPs) …
parameters have been reported in phase III trials with breast cancer patients (BCPs) …
External beam re-irradiation, combination chemoradiotherapy, and particle therapy for the treatment of recurrent glioblastoma
…, LC Mendez, K Beal, GN Marta - Expert review of …, 2016 - Taylor & Francis
Glioblastoma is a common aggressive primary malignant brain tumor, and is nearly universal
in progression and mortality after initial treatment. Re-irradiation presents a promising …
in progression and mortality after initial treatment. Re-irradiation presents a promising …
[HTML][HTML] The hidden curve behind COVID-19 outbreak: the impact of delay in treatment initiation in cancer patients and how to mitigate the additional risk of dying—the …
LL Matos, CHQ Forster, GN Marta… - Cancer Causes & …, 2021 - Springer
Purpose The rapid spread of the SARS-CoV-2 pandemic around the world caused most
healthcare services to turn substantial attention to treatment of these patients and also to alter …
healthcare services to turn substantial attention to treatment of these patients and also to alter …
[HTML][HTML] Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of …
Objective: Apatinib is an oral TKI targeting VEGFR-2. Single-agent apatinib treatment has
been shown to produce an objective response in patients with pretreated mBC. Oral …
been shown to produce an objective response in patients with pretreated mBC. Oral …
